{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:04:06Z","timestamp":1789790646644,"version":"4.0.1"},"reference-count":37,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,9,15]]},"DOI":"10.2169\/internalmedicine.5714-25","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T22:07:57Z","timestamp":1769897277000},"page":"2483-2488","source":"Crossref","is-referenced-by-count":0,"title":["Severe Brain Atrophy after Allogeneic Hematopoietic Stem Cell Transplantation in a Patient Suffering from Chronic Graft-versus-host Disease"],"prefix":"10.2169","volume":"65","author":[{"given":"Yasutaka","family":"Masuda","sequence":"first","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reo","family":"Yoshioka","sequence":"additional","affiliation":[{"name":"Department of Neurology, The University of Tokyo Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Neurology, The University of Tokyo Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Sudo","sequence":"additional","affiliation":[{"name":"Department of Neurology, The University of Tokyo Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsushi","family":"Toda","sequence":"additional","affiliation":[{"name":"Department of Neurology, The University of Tokyo Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mineo","family":"Kurokawa","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Japan"},{"name":"Department of Cell Therapy and Transplantation Medicine, The University of Tokyo Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Sakellari I, Gavriilaki E, Papagiannopoulos S, et al. Neurological adverse events post allogeneic hematopoietic cell transplantation: major determinants of morbidity and mortality. J Neurol 266: 1960-1972, 2019.","DOI":"10.1007\/s00415-019-09372-3"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Grauer O, Wolff D, Bertz H, et al. Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease. Brain 133: 2852-2865, 2010.","DOI":"10.1093\/brain\/awq245"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Sakura T, Hayakawa F, Sugiura I, et al. High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: a phase III study by JALSG. Leukemia 32: 626-632, 2018.","DOI":"10.1038\/leu.2017.283"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Harris AC, Young R, Devine S, et al. International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium. Biol Blood Marrow Transplant 22: 4-10, 2016.","DOI":"10.1016\/j.bbmt.2015.09.001"},{"key":"5","unstructured":"5. Kato S, Shimogaki H, Onodera A, et al. Development of the revised version of Hasegawa&apos;s dementia scale. Ronen Seishin Igaku Zasshi (Jpn J Geriatr Psychiatry) 2: 1339-1347, 1991 (in Japanese)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Jeong JW, Kim KW, Lee DY, et al. A normative study of the Revised Hasegawa Dementia Scale: comparison of demographic influences between the Revised Hasegawa Dementia Scale and the Mini-Mental Status Examination. Dement Geriatr Cogn Disord 24: 288-293, 2007.","DOI":"10.1159\/000107592"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Phillips KM, McGinty HL, Cessna J, et al. A systematic review and meta-analysis of changes in cognitive functioning in adults undergoing hematopoietic cell transplantation. Bone Marrow Transplant 48: 1350-1357, 2013.","DOI":"10.1038\/bmt.2013.61"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Harder H, Cornelissen JJ, Van Gool AR, Duivenvoorden HJ, Eijkenboom WM, van den Bent MJ. Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. Cancer 95: 183-192, 2002.","DOI":"10.1002\/cncr.10627"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Booth-Jones M, Jacobsen PB, Ransom S, Soety E. Characteristics and correlates of cognitive functioning following bone marrow transplantation. Bone Marrow Transplant 36: 695-702, 2005.","DOI":"10.1038\/sj.bmt.1705108"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Wu LM, Kuprian N, Herbert K, et al. A mixed methods analysis of perceived cognitive impairment in hematopoietic stem cell transplant survivors. Palliat Support Care 17: 396-402, 2019.","DOI":"10.1017\/S1478951518000664"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Sun CL, Francisco L, Baker KS, Weisdorf DJ, Forman SJ, Bhatia S. Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS). Blood 118: 4723-4731, 2011.","DOI":"10.1182\/blood-2011-04-348730"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Bevans M, El-Jawahri A, Tierney DK, et al. National Institutes of Health hematopoietic cell transplantation late effects initiative: The Patient-Centered Outcomes Working Group report. Biol Blood Marrow Transplant 23: 538-551, 2017.","DOI":"10.1016\/j.bbmt.2016.09.011"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Buchbinder D, Kelly DL, Duarte RF, et al. Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT. Bone Marrow Transplant 53: 535-555, 2018.","DOI":"10.1038\/s41409-017-0055-7"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kelly DL, Syrjala K, Taylor M, et al. Biobehavioral research and hematopoietic stem cell transplantation: expert review from the Biobehavioral Research Special Interest Group of the American Society for Transplantation and Cellular Therapy. Transplant Cell Ther 27: 747-757, 2021.","DOI":"10.1016\/j.jtct.2021.06.007"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Boberg E, Kadri N, Winterling J, et al. Mental fatigue after allogeneic hematopoietic stem cell transplantation is associated with cognitive dysfunction, but not central nervous system inflammation. Haematologica 105: e310-e314, 2020.","DOI":"10.3324\/haematol.2019.225326"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Boberg E, Iacobaeus E, Greenfield MS, Wang Y, Msghina M, Le Blanc K. Reduced prefrontal cortex and sympathetic nervous system activity correlate with fatigue after aHSCT. Bone Marrow Transplant 57: 360-369, 2022.","DOI":"10.1038\/s41409-021-01539-9"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Boberg E, Kadri N, Hagey DW, et al. Cognitive impairments correlate with increased central nervous system immune activation after allogeneic haematopoietic stem cell transplantation. Leukemia 37: 888-900, 2023.","DOI":"10.1038\/s41375-023-01840-0"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Sostak P, Padovan CS, Yousry TA, Ledderose G, Kolb HJ, Straube A. Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology 60: 842-848, 2003.","DOI":"10.1212\/01.WNL.0000046522.38465.79"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Correa DD, Root JC, Baser R, et al. A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipients. Brain Imaging Behav 7: 478-490, 2013.","DOI":"10.1007\/s11682-013-9221-8"},{"key":"20","unstructured":"20. Dage JL, Eloyan A, Thangarajah M, et al.; LEADS Consortium. Cerebrospinal fluid biomarkers in the longitudinal early-onset Alzheimer&apos;s disease study. Alzheimers Dement 19 (Suppl 9): S115-S125, 2023."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Seibert TM, Karunamuni R, Bartsch H, et al. Radiation dose-dependent hippocampal atrophy detected with longitudinal volumetric magnetic resonance imaging. Int J Radiat Oncol Biol Phys 97: 263-269, 2017.","DOI":"10.1016\/j.ijrobp.2016.10.035"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Bhojwani D, Sabin ND, Pei D, et al. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia. J Clin Oncol 32: 949-959, 2014.","DOI":"10.1200\/JCO.2013.53.0808"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Brugnoletti F, Morris EB, Laningham FH, et al. Recurrent intrathecal methotrexate induced neurotoxicity in an adolescent with acute lymphoblastic leukemia: Serial clinical and radiologic findings. Pediatr Blood Cancer 52: 293-295, 2009.","DOI":"10.1002\/pbc.21764"},{"key":"24","unstructured":"24. Rollins N, Winick N, Bash R, Booth T. Acute methotrexate neurotoxicity: findings on diffusion-weighted imaging and correlation with clinical outcome. AJNR Am J Neuroradiol 25: 1688-1695, 2004."},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. van der Meulen M, Amaya JM, Dekkers OM, Meijer OC. Association between use of systemic and inhaled glucocorticoids and changes in brain volume and white matter microstructure: a cross-sectional study using data from the UK Biobank. BMJ Open 12: e062446, 2022.","DOI":"10.1136\/bmjopen-2022-062446"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Brown ES, Woolston DJ, Frol A, et al. Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol Psychiatry 55: 538-545, 2004.","DOI":"10.1016\/j.biopsych.2003.09.010"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Nguyen DM, Yassa MA, Tustison NJ, et al. The relationship between cumulative exogenous corticosteroid exposure and volumes of hippocampal subfields and surrounding structures. J Clin Psychopharmacol 39: 653-657, 2019.","DOI":"10.1097\/JCP.0000000000001120"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Cuvelier GDE, Schoettler M, Buxbaum NP, et al. Toward a better understanding of the atypical features of chronic graft-versus-host disease: a report from the 2020 National Institutes of Health Consensus Project Task Force. Transplant Cell Ther 28: 426-445, 2022.","DOI":"10.1016\/j.jtct.2022.05.038"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Li M, Zhang Y, Guan Y, et al. A case report of central nervous system graft-versus-host disease and literature review. Front Neurol 12: 621392, 2021.","DOI":"10.3389\/fneur.2021.621392"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Takahashi K, Katayama T, Ichikawa T, et al. Possible chronic graft-versus-host disease in the central nervous system manifesting as cerebellar ataxia after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia. Intern Med 62: 779-786, 2023.","DOI":"10.2169\/internalmedicine.9720-22"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Adams RC, Carter-Cusack D, Shaikh SN, et al. Donor bone marrow-derived macrophage MHC II drives neuroinflammation and altered behavior during chronic GVHD in mice. Blood 139: 1389-1408, 2022.","DOI":"10.1182\/blood.2021011671"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Tsoi KK, Chan JY, Hirai HW, Wong SY, Kwok TC. Cognitive tests to detect dementia: a systematic review and meta-analysis. JAMA Intern Med 175: 1450-1458, 2015.","DOI":"10.1001\/jamainternmed.2015.2152"},{"key":"33","unstructured":"33. Kazui H, Watamori TS, Honda R, Tokimasa A, Hirono N, Mori E. The validation of the Japanese version of the Rivermead Behavioural Memory Test: a test for everyday memory. Shinkei Kenkyu no Shinpo (Adv Neurol Sci) 46: 307-318, 2002 (in Japanese)."},{"key":"34","unstructured":"34. Takahashi T. [Benton Visual Memory Test] Benton Shikaku Kimei Kensa. Sankyobo, Kyoto, 1966 (in Japanese)."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Slachevsky A, Villalpando JM, Sarazin M, Hahn-Barma V, Pillon B, Dubois B. Frontal assessment battery and differential diagnosis of frontotemporal dementia and Alzheimer disease. Arch Neurol 61: 1104-1107, 2004.","DOI":"10.1001\/archneur.61.7.1104"},{"key":"36","unstructured":"36. Japan Society for Higher Brain Dysfunction Brain Function Test Committee. [Clinical Assessment for Spontaneity (CAS)]. Shinkoh Igaku Shuppansha, Tokyo, 2006 (in Japanese)."},{"key":"37","unstructured":"37. Japan Society for Higher Brain Dysfunction Brain Function Test Committee. [Trail Making Test Japanese Version (TMT-J)] Trail Making Test Nihongo-ban (TMT-J). Shinkoh Igaku Shuppansha, Tokyo, 2019 (in Japanese)."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/18\/65_5714-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:31:40Z","timestamp":1789788700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/18\/65_5714-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":37,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5714-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"article-number":"5714-25"}}